It was indicated that therapeutic strategies in heterozygous FH patients that utilize agents that enhance LDLR expression could induce ER stress in the cells due to enhanced expression of the misfolded LDLR as well. This evidence concerns the gene LDLR and familial hyperaldosteronism.